ReviewOrphanet journal of rare diseases2020

The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis.

Inaugural Amyloidosis Forum Panelists et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.